InvestSMART

EZZ Life Science Holdings Limited (ASX: EZZ) - Share Price

Current share price for EZZ : $0.300 0.005 (1.64%)+

EZZ Life Science Holdings Limited (EZZ) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a genomic life sciences company with a mission to advance quality of life and human health by leveraging cutting-edge genomic research and innovative products to address health challenges.

EZZ General Information +

ASX Code EZZ
Website http://ezzlife.com.au
Industry/Sector Life Sciences Tools & Services
Market Cap ($M) 14
EZZ Share Price $0.300
Day High $0.305
Day Low $0.300
Last Close $0.305
EZZ Share Price Movement $0.01 ( 1.64% )
Prices as at 16:40, 6 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

EZZ Life Science Holdings Limited (EZZ) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 2¢ 100% 24 Nov 2025 23 Dec 2025 - - -
Result 2¢ 100% 16 May 2025 17 Jun 2025 - - -
HFResult 2¢ 100% 5 Nov 2024 9 Dec 2024 - - -

See all dividends from EZZ Life Science Holdings Limited (EZZ) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

EZZ Life Science Holdings Limited (EZZ) price-sensitive announcements

EZZ - Quarterly Activity and Cashflow Report
EZZ Life Science Holdings Limited’s Appendix 4C and Quarterly Activity Report for the quar
EZZ Life Science Holdings Limited (EZZ)
30 Oct 2026 | 4:57 PM
EZZ - Preliminary Final Report
EZZ Life Science Holdings Limited’s Appendix 4E Preliminary Final Report for the Australia
EZZ Life Science Holdings Limited (EZZ)
31 Aug 2026 | 6:59 PM
EZZ - Quarterly Activity and Cashflow Report
EZZ Life Science Holdings Limited reported their quarterly activities and cash flow status
EZZ Life Science Holdings Limited (EZZ)
31 Jul 2026 | 3:49 PM
EZZ - Quarterly Activity and Cashflow Report
EZZ Life Science Holdings Limited released its Quarterly Activity and Cashflow Report for
EZZ Life Science Holdings Limited (EZZ)
30 Apr 2026 | 4:54 PM

EZZ Life Science Holdings Limited (EZZ) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 Quarterly Activity and Cashflow Report 30 Oct 2026 4:57PM $0.305 $0.300 fallen by 1.64%
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 Annual General Meeting - Notice of Access 27 Oct 2026 5:00PM $0.305 $0.300 fallen by 1.64%
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 Notice of Annual General Meeting/Proxy Form 27 Oct 2026 4:59PM $0.305 $0.300 fallen by 1.64%
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 Change of Director's Interest Notice 11 Sep 2026 4:17PM $0.450 $0.300 fallen by 33.33%
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 EZZ Corporate Governance Statement and Appendix 4G 1 Sep 2026 9:41AM $0.585 $0.300 fallen by 48.72%
EZZ Life Science Holdings Limited (EZZ)
ORDINARY FULLY PAID
Health Care $14 Annual Report to shareholders 1 Sep 2026 8:11AM $0.585 $0.300 fallen by 48.72%

EZZ Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$4.70 -$10.00 -168.70% 0.00 0.00 0.00% 0.0%
2025A $6.73 $14.60 -10.00% 16.10 4.00 1.70% 100.0%
2024A $6.96 $16.20 90.20% 4.30 1.50 2.20% 100.0%

EZZ Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
EZZ Life Science Holdings Limited (EZZ) $14M -1.6866 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

EZZ Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 0.58 0.00
Market 0.30 13.40 1.03 0.75
Sector 0.78 33.40 2.19 2.23

EZZ Directors

Name Position Start Date
Mr Mark (Qizhou) Qin Chief Executive Officer, Executive Director 1 Sep 2018
Ms Christine Chen Executive Director 16 Jan 2026
Mr Gary Liu Non-Executive Chairman, Non-Executive Director 22 Jan 2026
Mr Ivan Oshry Non-Executive Director 27 Oct 2020
Ms Lily (Hao) Huang Non-Executive Director 27 Oct 2020
Ms Janice Hsu Non-Executive Director 16 Jan 2026

EZZ Life Science Holdings Limited (EZZ) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
8 Sep 2026 CHEN, Christine Sell Direct Shares 30,900 $0.478 $14,770.200
11 Dec 2024 QIN, Mark (Qizhou) Buy Indirect Shares 90,830 $2.710 $246,149.300
10 Dec 2024 QIN, Mark (Qizhou) Issued Related Securities 30,000 $0.180 $5,400.000

See all changes in directors' interest & trades for EZZ Life Science Holdings Limited (EZZ) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EZZ Management

Name Position
Anthony Guarna CFO
Jay Richard Stephenson Company Secretary

EZZ Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in EZZ Life Science Holdings Limited (EZZ). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
17,016,000 (36.15%) Macquarie Holdings Pty Ltd
12,344,000 (26.23%) JNJ Mok Pty Ltd

EZZ Calendar of Events

Date Event
31 August 2027 Report (Annual)
30 August 2027 Report (Prelim)
26 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.